Literature DB >> 16600964

Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.

Lee Frego1, Walter Davidson.   

Abstract

HXMS (hydrogen/deuterium exchange mass spectrometry) of the glucocorticoid receptor ligand-binding domain (GR LBD) complexed with the agonist dexamethasone and the antagonist RU-486 is described. Variations in the rates of exchange were observed in regions consistent with the published crystal structures of GR LBD complexed with RU-486 when compared with the GR dexamethasone complex. We also report the HXMS results for agonist-bound GR LBD with the coactivator transcriptional intermediary factor 2 (TIF2) and anatagonist-bound GR LBD with nuclear receptor corepressor (NCoR). Alterations in exchange rates observed for agonist-bound GR LBD with TIF2 present were consistent with the published crystal structural contacts for the complex. Alterations in exchange rates observed for antagonist-bound GR LBD with NCoR were a subset of those observed with TIF2 binding, suggesting a common or overlapping binding site for coactivator and corepressor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600964      PMCID: PMC2242475          DOI: 10.1110/ps.051781406

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  23 in total

Review 1.  New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting.

Authors:  H M Reichardt; F Tronche; S Berger; C Kellendonk; G Schütz
Journal:  Adv Pharmacol       Date:  2000

2.  Mechanism of corepressor binding and release from nuclear hormone receptors.

Authors:  L Nagy; H Y Kao; J D Love; C Li; E Banayo; J T Gooch; V Krishna; K Chatterjee; R M Evans; J W Schwabe
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

Review 3.  Molecular mechanisms of glucocorticosteroid actions.

Authors:  I M Adcock
Journal:  Pulm Pharmacol Ther       Date:  2000       Impact factor: 3.410

4.  The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism.

Authors:  Björn Kauppi; Clarissa Jakob; Mathias Färnegårdh; Jie Yang; Harri Ahola; Maria Alarcon; Karin Calles; Owe Engström; John Harlan; Steven Muchmore; Anna-Karin Ramqvist; Susanne Thorell; Lars Ohman; Jonathan Greer; Jan-Ake Gustafsson; Jan Carlstedt-Duke; Mats Carlquist
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

Review 5.  Mechanisms involved in the side effects of glucocorticoids.

Authors:  Heike Schäcke; Wolf Dietrich Döcke; Khusru Asadullah
Journal:  Pharmacol Ther       Date:  2002-10       Impact factor: 12.310

6.  A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects.

Authors:  Michael J Coghlan; Peer B Jacobson; Ben Lane; Masaki Nakane; Chun Wei Lin; Steven W Elmore; Philip R Kym; Jay R Luly; George W Carter; Russell Turner; Curtis M Tyree; Junlian Hu; Marc Elgort; Jon Rosen; Jeffrey N Miner
Journal:  Mol Endocrinol       Date:  2003-02-13

7.  RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.

Authors:  Martin Schulz; Martin Eggert; Aria Baniahmad; Anja Dostert; Thorsten Heinzel; Rainer Renkawitz
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

8.  How many nuclear hormone receptors are there in the human genome?

Authors:  M Robinson-Rechavi; A S Carpentier; M Duffraisse; V Laudet
Journal:  Trends Genet       Date:  2001-10       Impact factor: 11.639

9.  Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell.

Authors:  K De Bosscher; W Vanden Berghe; L Vermeulen; S Plaisance; E Boone; G Haegeman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

10.  Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.

Authors:  Randy K Bledsoe; Valerie G Montana; Thomas B Stanley; Chris J Delves; Christopher J Apolito; David D McKee; Thomas G Consler; Derek J Parks; Eugene L Stewart; Timothy M Willson; Millard H Lambert; John T Moore; Kenneth H Pearce; H Eric Xu
Journal:  Cell       Date:  2002-07-12       Impact factor: 41.582

View more
  19 in total

1.  Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled.

Authors:  Samuel J Pfaff; Robert J Fletterick
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  Differential modulation of glucocorticoid and progesterone receptor transactivation.

Authors:  Daniele Szapary; Liang-Nian Song; Yuangzheng He; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2007-12-08       Impact factor: 4.102

3.  Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone.

Authors:  Liping Yang; David Broderick; Yuan Jiang; Victor Hsu; Claudia S Maier
Journal:  Biochim Biophys Acta       Date:  2014-06-18

Review 4.  Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Mol Pharmacol       Date:  2012-08-06       Impact factor: 4.436

5.  In silico discovery of androgen receptor antagonists with activity in castration resistant prostate cancer.

Authors:  Howard C Shen; Kumaran Shanmugasundaram; Nicholas I Simon; Changmeng Cai; Hongyun Wang; Sen Chen; Steven P Balk; Alan C Rigby
Journal:  Mol Endocrinol       Date:  2012-09-28

6.  Probing Dominant Negative Behavior of Glucocorticoid Receptor β through a Hybrid Structural and Biochemical Approach.

Authors:  Jungki Min; Lalith Perera; Juno M Krahn; Christine M Jewell; Andrea F Moon; John A Cidlowski; Lars C Pedersen
Journal:  Mol Cell Biol       Date:  2018-03-29       Impact factor: 4.272

7.  Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211.

Authors:  Melanie Patt; Joël Gysi; Nourdine Faresse; John A Cidlowski; Alex Odermatt
Journal:  Mol Cell Endocrinol       Date:  2020-06-22       Impact factor: 4.102

Review 8.  A current structural perspective on PXR and CAR in drug metabolism.

Authors:  Cameron D Buchman; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-05-30       Impact factor: 4.481

Review 9.  What goes on behind closed doors: physiological versus pharmacological steroid hormone actions.

Authors:  S Stoney Simons
Journal:  Bioessays       Date:  2008-08       Impact factor: 4.345

10.  Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile.

Authors:  Jeffrey N Miner; Bob Ardecky; Khalid Benbatoul; Kimberly Griffiths; Christopher J Larson; Dale E Mais; Keith Marschke; Jon Rosen; Eric Vajda; Lin Zhi; Andres Negro-Vilar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.